Dexamethasone in endodontics has been investigated as an adjunctive anti-inflammatory agent for reducing postoperative pain associated with root canal treatment.
📌 Recommended Article :
Dental Article 🔽 Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy ... Pulpectomy in primary teeth requires obturation materials that ensure antimicrobial efficacy, biocompatibility, and physiological resorption.Its primary therapeutic effect is the suppression of inflammatory mediators involved in periapical inflammation and nociceptive sensitization.
Advertisement
Two main approaches have been explored: local administration, including intracanal application and corticosteroid-containing irrigation protocols, and systemic administration, particularly oral and injectable routes.
Although clinical studies suggest that dexamethasone can reduce postoperative pain, its effectiveness depends on the administration route, clinical indication, and patient characteristics.
It is important to distinguish its analgesic role from definitive endodontic treatment: corticosteroids do not eliminate microorganisms or replace adequate chemomechanical preparation and disinfection.
📌 Recommended Article :
Dental Article 🔽 CTZ Paste in Pediatric Dentistry: Indications, Composition, and Success Rates ... This technique, often referred to as non-instrumentation endodontic treatment (NIET), has gained attention due to its simplicity, reduced chair time, and favorable outcomes in young or uncooperative children.✅ Mechanism of Action
Dexamethasone is a potent synthetic glucocorticoid that reduces inflammation through several mechanisms:
▪️ Phospholipase A2 inhibition: Reduces the production of prostaglandins and leukotrienes by inhibiting arachidonic acid release.
▪️ Cytokine suppression: Decreases the expression of pro-inflammatory mediators, including IL-1, IL-6, and TNF-α.
▪️ Reduced vascular permeability: Limits inflammatory edema and tissue swelling.
▪️ Modulation of nociception: Reduces peripheral inflammatory sensitization, contributing to postoperative pain relief.
These effects may be particularly relevant in teeth with symptomatic irreversible pulpitis, symptomatic apical periodontitis, and postoperative inflammatory pain.
📌 Recommended Article :
Dental Article 🔽 Dexamethasone in Endodontics: Benefits Beyond Injections ... Dexamethasone is a potent glucocorticoid that suppresses inflammatory mediator production and modulates the host inflammatory response.✅ Intracanal Dexamethasone: Indications and Clinical Evidence
Intracanal dexamethasone has been investigated as a local approach to reduce inflammatory responses following root canal instrumentation.
Its application has primarily been studied as a final intracanal rinse rather than as a conventional long-term intracanal medicament.
Main applications
▪️ Final intracanal irrigation: Administration after chemomechanical preparation to reduce postoperative inflammatory pain.
▪️ Symptomatic irreversible pulpitis: An adjunctive approach in patients at increased risk of postoperative discomfort.
▪️ Post-instrumentation inflammation: Potential reduction of inflammatory responses associated with mechanical and chemical irritation of periapical tissues.
Scientific evidence
A randomized clinical trial involving 60 patients with symptomatic irreversible pulpitis evaluated dexamethasone (4 mg/mL) as a final intracanal rinse. The reported effectiveness in relieving postoperative pain was 86.67%, compared with 20% in the saline control group.
Other clinical investigations have also evaluated dexamethasone solutions as final irrigants, reporting reductions in postoperative pain. However, differences in protocols, sample sizes, and outcome measurements limit the generalizability of these findings.
Important distinction: Intracanal dexamethasone irrigation should not be confused with placing corticosteroid preparations inside the canal as an interappointment dressing. Evidence supporting routine use of dexamethasone as a standalone intracanal medicament remains insufficient.
📌 Recommended Article :
Dental Article 🔽 Why Hydrogen Peroxide Should Not Be Used in Modern Endodontic Treatment: Evidence-Based Clinical Justification ... This article explains why hydrogen peroxide is no longer recommended in endodontic treatments, supported by contemporary scientific evidence.✅ Systemic Dexamethasone: Indications and Clinical Evidence
Systemic dexamethasone has a more extensive clinical evidence base than direct intracanal application, particularly for reducing postoperative endodontic pain.
It has been administered through different routes:
▪️ Oral administration: Preoperative or perioperative administration.
▪️ Intramuscular injection: Used in selected clinical protocols.
▪️ Supraperiosteal or intraligamentary injection: Local injection with systemic corticosteroid activity, investigated for preemptive pain control.
Clinical indications
Systemic administration may be considered in selected patients presenting with:
▪️ Symptomatic irreversible pulpitis with significant preoperative pain.
▪️ Increased risk of postoperative inflammatory pain.
▪️ Anticipated postoperative discomfort following endodontic procedures.
▪️ Situations in which conventional analgesic management requires an individualized adjunctive approach.
Evidence from systematic reviews
A 2024 systematic review and meta-analysis by Alajlan et al. included 29 clinical trials involving 2,303 participants.
The results demonstrated that corticosteroid administration reduced the likelihood of postoperative pain at:
▪️ 6 hours: RR = 2.50.
▪️ 12 hours: RR = 2.10.
▪️ 24 hours: RR = 1.77.
The authors rated the certainty of evidence as moderate, supporting a clinically relevant reduction in postoperative endodontic pain. These findings concern systemic and locally injected corticosteroids collectively, not dexamethasone exclusively.
A further systematic review published in 2026 evaluated nine randomized clinical trials involving 917 participants. It found that preemptive corticosteroid injections, particularly dexamethasone administered through infiltrative routes, reduced postoperative pain, with the greatest effects during the first 24 hours.
📌 Recommended Article :
Dental Article 🔽 Triple Antibiotic Paste (TAP) in Pediatric Endodontics: Current Clinical Evidence ... Triple Antibiotic Paste (TAP) has gained significant attention in pediatric endodontics, particularly in the management of necrotic primary teeth and immature permanent teeth.✅ Intracanal vs. Systemic Dexamethasone
The two approaches differ in their administration, intended distribution, and strength of supporting evidence.
| Parameter | Intracanal Dexamethasone | Systemic Dexamethasone |
|---|---|---|
| Administration | Final canal rinse or local application | Oral or injectable |
| Main objective | Local inflammatory modulation | Systemic anti-inflammatory effect |
| Primary application | Post-instrumentation pain reduction | Preemptive or postoperative pain control |
| Evidence | Limited clinical trials | Systematic reviews and meta-analyses |
| Systemic exposure | Expected to be lower, but not necessarily absent | Expected and clinically relevant |
| Routine use | Not established | Not routinely indicated for every case |
There is no universally established dexamethasone protocol for endodontic treatment. Published clinical trials have investigated different doses, administration routes, and timing.
For example, a 2026 randomized clinical trial evaluated 4 mg oral dexamethasone administered one hour before treatment in 82 patients. The dexamethasone group showed lower postoperative pain scores than the ibuprofen comparison group between 6 and 24 hours. Nevertheless, the limited sample size and single-center design warrant further validation.
Clinical precautions
Before prescribing systemic dexamethasone, clinicians should assess:
▪️ History of hypersensitivity to corticosteroids. ▪️ Uncontrolled diabetes mellitus. ▪️ Active or untreated infections. ▪️ Peptic ulcer disease and relevant gastrointestinal risks. ▪️ Immunosuppression and other conditions potentially aggravated by corticosteroids. ▪️ Pregnancy, lactation, and concomitant medication use.
Potential adverse effects include transient hyperglycemia, gastrointestinal disturbances, sleep disturbances, mood changes, and immunosuppressive effects.
Short-term administration generally presents fewer risks than prolonged corticosteroid exposure, but it is not risk-free.
Intracanal administration also requires caution. The solution must not compromise the effectiveness of canal disinfection, and extrusion beyond the apical foramen should be avoided.
📌 Recommended Article :
Dental Article 🔽 Zinc Oxide–Eugenol Paste in Modern Dentistry: Current Uses, Benefits, and Limitations ... Despite the emergence of bioactive and resin-based alternatives, ZOE continues to play a role in specific clinical situations due to its sedative, antimicrobial, and sealing properties.💬 Discussion
The available evidence supports dexamethasone as a potentially useful adjunct for controlling postoperative endodontic pain, particularly during the first 24 hours.
However, the evidence is not equally strong for both administration routes. Systemic corticosteroids have been evaluated in a substantially larger number of clinical trials, whereas intracanal application remains supported by fewer studies and less standardized protocols.
An important consideration is that pain reduction does not necessarily indicate improved periapical healing or long-term endodontic success. Corticosteroids suppress inflammation but do not provide antimicrobial activity.
Furthermore, the clinical benefit must be balanced against patient-specific contraindications and the availability of conventional analgesic strategies.
Future randomized clinical trials should directly compare intracanal and systemic dexamethasone, establish optimal administration protocols, and evaluate both short-term pain control and longer-term clinical outcomes.
🎯 Clinical Recommendations
Based on the available evidence, the following recommendations are appropriate for clinical practice:
1. Prioritize definitive endodontic treatment: Adequate instrumentation, irrigation, working-length control, and apical debridement remain fundamental to controlling endodontic inflammation.
2. Consider systemic dexamethasone selectively: It may be considered as an adjunct in carefully selected patients with significant inflammatory pain, following medical history assessment and contraindication screening.
3. Use intracanal dexamethasone cautiously: Its use as a final rinse remains promising, but insufficient evidence supports its routine incorporation into standard irrigation protocols.
4. Avoid substituting corticosteroids for analgesics or disinfection: Dexamethasone should not replace appropriate analgesic therapy, antimicrobial procedures, or drainage when clinically indicated.
5. Reassess persistent symptoms: Increasing pain, swelling, or systemic manifestations require evaluation for persistent infection, inadequate drainage, or other treatment-related complications.
✍️ Conclusion
Dexamethasone in endodontics represents a potentially valuable adjunct for managing postoperative inflammatory pain. Systemic administration has stronger supporting evidence, with systematic reviews demonstrating significant pain reduction during the first 24 hours after treatment.
Intracanal administration, particularly as a final irrigation solution, has also demonstrated promising results, although its clinical evidence remains limited.
Ultimately, dexamethasone should be used selectively and as an adjunct to evidence-based endodontic treatment, rather than as a substitute for adequate canal disinfection and conventional pain management.
📚 References
✔ Alajlan, N., Carrasco-Labra, A., Karabucak, B., & Lee, S. M. (2024). Systemic corticosteroid uses in endodontics—Part 1: Managing postoperative pain. Journal of Endodontics, 50(6), 724–734. https://doi.org/10.1016/j.joen.2024.03.004
✔ Dildar, I., Moghal, A., Mirza, A., Zaheer, M. A., Mallick, M. R., & Munir, S. (2024). Evaluation of postoperative pain after using dexamethasone intracanal rinse in irreversible pulpitis. Journal of the College of Physicians and Surgeons Pakistan, 34(4), 390–393. https://doi.org/10.29271/jcpsp.2024.04.390
✔ Nogueira, B. M. L., Silva, L. G., Mesquita, C. R. M., Menezes, S. A. F., Menezes, T. O. A., Faria, A. G. M., & Porpino, M. T. M. (2018). Is the use of dexamethasone effective in controlling pain associated with symptomatic irreversible pulpitis? A systematic review. Journal of Endodontics, 44(5), 703–710. https://doi.org/10.1016/j.joen.2018.02.006
✔ Nath, R., Daneshmand, A., Sizemore, D., Guo, J., & Enciso, R. (2018). Efficacy of corticosteroids for postoperative endodontic pain: A systematic review and meta-analysis. Journal of Dental Anesthesia and Pain Medicine, 18(4), 205–221. https://doi.org/10.17245/jdapm.2018.18.4.205
✔ Al-Yamoor, R., Stefanescu, S. V., Iuga, M. M., Espada-Salgado, F. M., Bilsborrow, S., Teja, K. V., & Vasundhara, K. A. (2026). Effect of pre-emptive injection-based corticosteroid administration and its routes on post-endodontic pain: A systematic review and meta-analysis of randomized clinical trials. Journal of Clinical and Experimental Dentistry, 18(5), e688–e703. https://doi.org/10.4317/jced.64027
✔ Nils, H. J., Arce Recatalá, C., Galletti, C., & Flores-Fraile, J. (2026). Therapeutic management of dexamethasone in patients undergoing endodontics: A randomized clinical trial. Odontology, 114(4), 2158–2169. https://doi.org/10.1007/s10266-025-01277-0
📌 More Recommended Items
► Why Is Dental Pain More Intense at Night?
► Pulp Necrosis in Primary Teeth: Diagnosis and Evidence-Based Management
► CTZ Paste in Primary Teeth Pulp Therapy: Indications, Benefits and Clinical Protocol